Privacy-Preserving Search on Medical Data.

Stud Health Technol Inform

Department of Computer Science, Trier University of Applied Sciences, Trier, Germany.

Published: August 2024

Data sharing spaces for medical data are necessary to facilitate research. To make medical data available for research, a mechanism is preferable that not only provides data a researcher has legal access to, but also contributes to the investigation of their specific research hypothesis. We propose a three-party two-stage search algorithm initiated by a researcher on centrally stored but technically and organizationally separated data. The search seeks to minimize the risk of reidentification of patients and to enable data minimization. In the first stage, we only access data IDs of patients meeting the cohort criteria. In the second stage, the actual data is downloaded if the set of matching patients satisfies the minimum cohort size. Our approach is privacy preserving, as only the researcher is able to connect medical and demographic data, while no single malicious party can get data access. We thereby hope to pave the way for a privacy-aware health data sharing space as currently proposed by the EU.

Download full-text PDF

Source
http://dx.doi.org/10.3233/SHTI240392DOI Listing

Publication Analysis

Top Keywords

data
12
medical data
12
data sharing
8
privacy-preserving search
4
medical
4
search medical
4
data data
4
sharing spaces
4
spaces medical
4
data facilitate
4

Similar Publications

Global Use, Adaptation, and Sharing of Massive Open Online Courses for Emergency Health on the OpenWHO Platform: Survey Study.

J Med Internet Res

January 2025

Learning and Capacity Development Unit, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.

Background: The COVID-19 pandemic demonstrated the global need for accessible content to rapidly train health care workers during health emergencies. The massive open access online course (MOOC) format is a broadly embraced strategy for widespread dissemination of trainings. Yet, barriers associated with technology access, language, and cultural context limit the use of MOOCs, particularly in lower-resource communities.

View Article and Find Full Text PDF

Introduction: Varenicline is an α4β2 nicotinic acetylcholine receptor partial agonist with the highest therapeutic efficacy of any pharmacological smoking cessation aid and a 12-month cessation rate of 26%. Genetic variation may be associated with varenicline response, but to date no genome-wide association studies of varenicline response have been published.

Methods: In this study, we investigated the genetic contribution to varenicline effectiveness using two electronic health record-derived phenotypes.

View Article and Find Full Text PDF

Genes encoding OXA-48-like carbapenem-hydrolyzing enzymes are often located on plasmids and are abundant among carbapenemase-producing (CPE) worldwide. After a large plasmid-mediated outbreak in 2011, routine screening of patients at risk of CPE carriage on admission and every 7 days during hospitalization was implemented in a large hospital in the Netherlands. The objective of this study was to investigate the dynamics of the hospitals' 2011 outbreak-associated plasmid among CPE collected from 2011 to 2021.

View Article and Find Full Text PDF

The Association Between Dietary Supplement Use and COVID-19 Symptoms.

J Diet Suppl

January 2025

Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

The scientific evidence supporting recommendations for dietary supplement use to prevent or treat coronavirus disease 2019 (COVID‑19) is not well‑established. This cohort study investigates the relationship between dietary supplement usage and COVID‑19 symptoms among 27,181 adults tested for COVID‑19. Using data from surveys following COVID‑19 testing, conducted by the University of Arkansas for Medical Sciences, associations between dietary supplement usage, symptomatology, and COVID‑19 status were explored.

View Article and Find Full Text PDF

Development and Validation of a Brief Age-Normed Screening Tool for Subthreshold Psychosis Symptoms in Youth.

Schizophr Bull

January 2025

Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Background And Hypothesis: Improvements in screening tools for early subthreshold psychosis symptoms are needed to facilitate early identification and intervention efforts, especially given the challenges of rapidly differentiating age-appropriate experiences from potential early signs of emerging psychosis. Tools can be lengthy and time-consuming, impacting their utility and accessibility across clinical settings, and age-normed data are limited. To address this gap, we sought to develop and validate a brief, empirically derived, age-normed, subthreshold psychosis screening tool, for public use.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!